Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 0.37% today. In the last week its performance is 1.31%, and 14.24% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 467.45, so today’s gain of 0.37% is a significant step towards its target price. The GAP today is therefore 0.56%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 42343.28, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 70.90%.

At the current price of 408.01, it has a dividend yield of *TBA, and its target price is 467.45. This is with a profit margin of 16.00%, and total debt/equity of 0.09. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 63.69, as well as a forward P/E of 28.28.

With a current EPS of 6.41, and a forecasted EPS growth for next year at 32.05%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 18.62%.

Performance for the year is -23.95%. Since its IPO date on 4/2/1991, the total performance to date is -24.84%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 614500, while its average volume is 784.76. Whilst the total gain today was 0.37%, it did have a day high of -8.10%.

Volatility for this week has been at 2.30%, and 2.63% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 23.98%, while the 52-week-high has reached -31.15%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.00%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 26.70%. With a sales growth of 21.40% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.09, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.42, and the P/S is 9.11, along with a P/B of 10.47. Meanwhile it has a p/cash of 40.51.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment